Dapagliflozin: A Review in Type 2 Diabetes

Dhillon, S

Dhillon, S (reprint author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2019; 79 (10): 1135

Abstract

Dapagliflozin (Forxiga((R))) is a highly potent, reversible and selective sodium-glucose cotransporter-2 inhibitor indicated worldwide for the treatme......

Full Text Link